Use of botulinim toxin-A for the treatment of overactive bladder symptoms in patients with Parkinsons's disease

Parkinsonism & Related Disorders
Haluk Kulaksizoglu, Yesim Parman

Abstract

To evaluate the efficacy of intravesical Botulinum toxin injection for overactive bladder symptoms in patients with Parkinson's disease. Parkinson's Disease patients with overactive bladder symptoms and incontinence were included in the study. Patients were interviewed using the SEAPI questionnaire. The caregivers evaluated their decline in quality of life using the visual analog scale. Intradetrusor injection technique with 30 point template was employed. All patients received 500 i.u. of botulinum toxin-A. The follow-up was at week one and every 12 weeks thereafter for 12 months. Primary caregiver quality of life assessments were also performed using the VAS scale in every visit. Sixteen patients were followed for 12 months. The mean age of the group was 67.2 +/- 5.1. Initial mean functional bladder capacity for the group was 198.6 +/- 33.7 mL.In the third month control the mean bladder capacity increased to 319 +/- 41.1 mL. The quality of life assessment of primary caregiver as well as the patients also statistically improved after the injections (p < 0.05 for both). No neurological detoriation, confusion or disorientation were noted. At the 9th month control 6 patients experienced some urgency which they could suppress and ...Continue Reading

Citations

Oct 12, 2011·Current Urology Reports·Lysanne CampeauKarl-Erik Andersson
Jan 4, 2012·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A ConteA Berardelli
Jun 2, 2012·Expert Review of Neurotherapeutics·Ronald F Pfeiffer
Feb 5, 2013·Expert Opinion on Emerging Drugs·Santiago Perez-LloretOlivier Rascol
Apr 3, 2013·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·V PhéUNKNOWN le Comité de neuro-urologie de l’Association française d’urologie
Oct 22, 2011·Neurobiology of Disease·Ryuji SakakibaraTatsuya Yamamoto
Jul 28, 2011·The Journal of Urology·Antonella GiannantoniAlfredo Berardelli
Oct 20, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·Keiichiro TerayamaTatsuya Yamamoto
May 11, 2012·International Journal of Urology : Official Journal of the Japanese Urological Association·Yue-Chen Kuo, Hann-Chorng Kuo
Mar 27, 2015·Neurourology and Urodynamics·Ryuji SakakibaraUNKNOWN Parkinson's Disease Subcomittee, The Neurourology Promotion Committee in The International Continence Society
Feb 28, 2014·International Journal of Urology : Official Journal of the Japanese Urological Association·Ryuji SakakibaraYosuke Aiba
Aug 12, 2015·Nature Reviews. Urology·Yuan-Hong JiangHann-Chorng Kuo
Nov 20, 2014·Current Neurology and Neuroscience Reports·Reversa MillsFernando Pagan
Aug 16, 2016·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Veronica A BrunoJanis M Miyasaki
Sep 30, 2016·Current Treatment Options in Neurology·Amit BatlaJalesh N Panicker
Dec 14, 2016·Nature Reviews. Urology·Teruyuki OgawaNaoki Yoshimura
May 10, 2017·The International Journal of Neuroscience·Arina MadanPinky Agarwal
Mar 6, 2018·Neurology India·Priyanka Tater, Sanjay Pandey
May 17, 2018·Neurourology and Urodynamics·Gregory VurtureBenjamin M Brucker
Nov 9, 2018·Neurourology and Urodynamics·Sakineh HajebrahimiHanieh Salehi-Pourmehr
Jan 21, 2020·Expert Opinion on Pharmacotherapy·Cecilia QuarracinoSantiago Pérez-Lloret
Aug 14, 2020·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Ronald F Pfeiffer
Nov 11, 2017·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·Ryuji SakakibaraTomonori Yamanishi
Mar 7, 2018·Movement Disorders : Official Journal of the Movement Disorder Society·Jose-Alberto Palma, Horacio Kaufmann
Jun 7, 2016·Movement Disorders Clinical Practice·Amit BatlaJalesh N Panicker
Feb 14, 2021·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·A AtamianG Karsenty
Jan 10, 2019·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·X BiardeauUNKNOWN pour Groupe de recherche appliquée à la pathologie pelvi-périnéale des personnes âgées (GRAPPPA)

❮ Previous
Next ❯

Related Concepts

Related Feeds

Botulism (ASM)

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

Botulism

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.